Shen L - Search Results

1

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients.

Wu X, Ye C, Wang X, Cai R, Yang J, Yu X, Zhou Y, Shen L, Zhu Y, Liu X. Wu X, et al. Among authors: shen l. Cancer Manag Res. 2021 Feb 15;13:1517-1527. doi: 10.2147/CMAR.S284638. eCollection 2021. Cancer Manag Res. 2021. PMID: 33623431 Free PMC article.

2

Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of N ⁶-Methyladenosine-Related Long Noncoding RNA Regulators in Breast Cancer.

Zhang X, Shen L, Cai R, Yu X, Yang J, Wu X, Zhu Y, Liu X. Zhang X, et al. Among authors: shen l. Front Cell Dev Biol. 2021 Jul 2;9:686675. doi: 10.3389/fcell.2021.686675. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34277627 Free PMC article.

3

Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer.

Zhang H, Yu X, Yang J, He G, Zhang X, Wu X, Shen L, Zhou Y, Cheng X, Liu X, Zhu Y. Zhang H, et al. Among authors: shen l. Front Immunol. 2022 Aug 25;13:933779. doi: 10.3389/fimmu.2022.933779. eCollection 2022. Front Immunol. 2022. PMID: 36090993 Free PMC article.

4

Crosstalk of RNA methylation writers defines tumor microenvironment and alisertib resistance in breast cancer.

Zhang X, Shen L, Zhu Y, Zhai C, Zeng H, Liu X, Tao J. Zhang X, et al. Among authors: shen l. Front Endocrinol (Lausanne). 2023 Sep 25;14:1166939. doi: 10.3389/fendo.2023.1166939. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37818090 Free PMC article.

5

Promotion effect of FOXCUT as a microRNA sponge for miR-24-3p on progression in triple-negative breast cancer through the p38 MAPK signaling pathway.

Yu X, Qian F, Zhang X, Zhu Y, He G, Yang J, Wu X, Zhou Y, Shen L, Shi X, Zhang H, Liu X. Yu X, et al. Among authors: shen l. Chin Med J (Engl). 2024 Jan 5;137(1):105-114. doi: 10.1097/CM9.0000000000002700. Epub 2023 Jul 20. Chin Med J (Engl). 2024. PMID: 38178324 Free PMC article.

6

Suppression of AGRN enhances CD8+ T cell recruitment and inhibits breast cancer progression.

Tao J, Shen L, Zhuang M, Zhai C, Zeng H, Mao Y, Liu X. Tao J, et al. Among authors: shen l. FASEB J. 2024 Apr 15;38(7):e23582. doi: 10.1096/fj.202302288R. FASEB J. 2024. PMID: 38568853

7

Exosomal circ-0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7/NRF2 axis.

Zhuang M, Zhang X, Ji J, Zhang H, Shen L, Zhu Y, Liu X. Zhuang M, et al. Among authors: shen l. Clin Transl Med. 2024 Aug;14(8):e1763. doi: 10.1002/ctm2.1763. Clin Transl Med. 2024. PMID: 39107958 Free PMC article.

8

Clinical implications of serum hypoxia inducible factor-1α and vascular endothelial growth factor in lung cancer.

Shen H, Feng G, Cui J, Du Q, Qin Y, Cai J, Shen L, Zhu Y. Shen H, et al. Among authors: shen l. Tumori. 2015 Jul-Aug;101(4):404-11. doi: 10.5301/tj.5000320. Epub 2015 May 13. Tumori. 2015. PMID: 25983091

9

The research progress of circular RNAs in hematological malignancies.

Ji T, Chen Q, Tao S, Shi Y, Chen Y, Shen L, Wang C, Yu L. Ji T, et al. Among authors: shen l. Hematology. 2019 Dec;24(1):727-731. doi: 10.1080/16078454.2019.1669924. Hematology. 2019. PMID: 31581903 Free article. Review.

10

PTIP Inhibits Cell Invasion in Esophageal Squamous Cell Carcinoma via Modulation of EphA2 Expression.

Han X, Zhu Y, Shen L, Zhou Y, Pang L, Zhou W, Gu H, Han K, Yang Y, Jiang C, Xie J, Zhang C, Ding L. Han X, et al. Among authors: shen l. Front Oncol. 2021 Mar 23;11:629916. doi: 10.3389/fonc.2021.629916. eCollection 2021. Front Oncol. 2021. PMID: 33833989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,639 results

Search Page

Filters